fashion -WSS

fashion

author：entertainment 2025-09-29 20:51:23 - browse：972

Medical illustration of Streptococcus pneumoniae bacteria — A medical illustration of drug-resistant, Streptococcus pneumoniae bacteria. Antibiotic Resistance Coordination and Strategy Unit/CDC

Micronoma, a San Diego-based biotech startup, was founded on the idea that signatures from microbes that colonize tumors could lead to a blood test to detect cancer. The hypothesis was based on a high-profile Nature paper, published in 2020, that suggested these microbes are consistently found in tumors, and that they create such specific signatures they could be used to identify cancer types with nearly 100% accuracy.

But late Monday night, a team of researchers published a manuscript on the preprint site bioRxiv.com showing what they believe to be two “fatal errors” in the Nature paper’s analyses, invalidating not only the paper’s findings but possibly the scientific foundation for Micronoma, which has raised an estimated $17.5 million in funding from investors including SymBiosis Capital Management and the Seerave Foundation.

One allegation is that the Nature paper’s authors didn’t adequately filter out human DNA from their database of tumor samples, leading them to incorrectly classify millions of human sequences as bacterial. The other is that a separate error led the team’s algorithm to find false associations between specific microbial signatures and cancer types.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： 30 years of 'Listening to Prozac'

hotspot

focus

WSS

Despite FDA concern, risk that CAR

30 years of 'Listening to Prozac'

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

BIO selects John Crowley as new CEO

Think you might have Covid

Disappointing trial forces Pfizer to pivot on obesity medicine plans

focus

fashion

Wikipedia

Sports medicine is finally prioritizing gender equality

Copay coupons to count toward deductibles, after Biden court move

Peter Hotez and the public health issue of online harassment

Parkinson’s finding may lead to tests and, someday, treatments

Peter Hotez and the public health issue of online harassment

BIO selects John Crowley as new CEO

New air purifier tech could be key to improving indoor air quality

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

The surgeon had a dilemma only a Nazi medical text could resolve

focus

ReNAgade cuts staff seven months after raising $300 million

Rep. Raul Ruiz on the physician shortage and more

The surgeon had a dilemma only a Nazi medical text could resolve

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

NIH director takes cautious approach to Biden drug pricing priority

eGenesis tests gene

hotspot

focus

knowledge

hotspot